Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic

Publication at First Faculty of Medicine, Third Faculty of Medicine |

2012

Abstract

In this review article the analysis is presented of the tratment results in advanced non-small cell lung cancer patients treated in the Ist line by erlotinib, gefitinib, bevacizumab and pemetrexed in the Czech Republic.

Keywords

TULUG NSCLC

Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic

Abstract

Keywords

People